Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids

: Browne, Shane; Monaghan, Michael; Brauchle, Eva; Carvajal Berrio, Daniel; Chantepie, Sandrine; Papy-Garcia, Dulce; Schenke-Layland, Katja; Pandit, Abhay

Fulltext (PDF; )

Biomaterials 69 (2015), pp.133-47
ISSN: 0142-9612
ISSN: 1878-5905
Journal Article, Electronic Publication
Fraunhofer IGB ()
Collagen; gene therapy; inflammation; Angiogenesis Extracellular Matrix (ECM)

Tissue-engineered organs and implants hold promise for the replacement of damaged and diseased organs. However, the foreign body response (FBR) is a major obstacle that compromises the function of tissue-engineered constructs, typically causing them to fail. Two components of FBR are an inflammatory response and a lack of vascularization. To overcome these limitations, a collagen system was developed to release interleukin-6 (IL-6) siRNA and endothelial nitric oxide synthase (eNOS) pDNA in a staggered manner. Hollow collagen microspheres were assembled into a collagen sphere-in-hydrogel system that displayed a staggered release profile in vitro. This system was assessed in vivo in a subcutaneous rat model. The doses of IL-6 siRNA and eNOS pDNA were first individually optimized for their ability to reduce the volume fraction of inflammatory cells (7 days) and increase the length density of blood vessels (14 days), respectively. The identified optimal doses were combined, and the ability of the system to decrease the volume fraction of inflammatory cells and increase the length density of blood vessels was confirmed at both 7 and 14 days. Analysis of the tissue using Raman microspectroscopy revealed that in addition to changes in inflammation and angiogenesis, there were also changes in the extracellular matrix (ECM) at seven days. While changes in sulfated glycosaminoglycan (sGAG) content of the ECM were not detected, changes in the binding of sGAG of the ECM to growth factors were observed. Two growth factors tested, VEGF165 and bFGF showed increased binding to sGAG extracted from eNOS pDNAtreated samples at seven days, increasing the angiogenic potential of the ECM. Thus, we observe that changes in the tissue in terms of the balance of inflammation and angiogenesis as well changes in the activity of sGAG of the ECM occurs following dual delivery of nucleic acids from the collagen sphere-inhydrogel system.